SCHEMBL12410220

SCHEMBL12410220

CC(=O)C(C)CCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16863785 1.00
SCHEMBL14870327 0.92 CA1 (0.41)
SCHEMBL1437768 0.90 CA1 (0.40)
SCHEMBL1715023 0.90 CA1 (0.40)
SCHEMBL12153331 0.86 CA1 (0.48)
SCHEMBL10957794 0.84 ACE2 (0.46)
SCHEMBL14459603 0.83
SCHEMBL15681461 0.83
SCHEMBL12153332 0.83 CA1 (0.46)
SCHEMBL1121771 0.81 CA1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170035898-A1 CONJUGATES OF AN IL-15 MOIETY AND A POLYMER NEKTAR THERAPEUTICS 2017-02-09 US disclosed
US-9493512-B2 Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates NOVARTIS AG (CH) 2016-11-15 US disclosed
US-20150218224-A1 Solution Phase Processes for the Manufacture of Macrocyclic Depsipeptides and New Intermediates NOVARTIS AG (CH) 2015-08-06 US disclosed
US-9067978-B2 Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates NOVARTIS AG (CH) 2015-06-30 US disclosed
US-20140044672-A1 CONJUGATES OF A GM-CSF MOIETY AND A POLYMER NEKTAR THERAPEUTICS (US) 2014-02-13 US disclosed
US-20130096258-A1 POLYMER CONJUGATES OF GLP-1 NEKTAR THERAPEUTICS (US) 2013-04-18 US disclosed
US-20110165113-A1 POLYMER CONJUGATES OF V681-LIKE PEPTIDES NEKTAR THERAPEUTICS (US) 2011-07-07 US disclosed